Reuters logo
BRIEF-Conatus Pharmaceuticals reports Q3 revenue of $9.6 million
November 1, 2017 / 8:46 PM / 24 days ago

BRIEF-Conatus Pharmaceuticals reports Q3 revenue of $9.6 million

Nov 1 (Reuters) - Conatus Pharmaceuticals Inc

* Conatus Pharmaceuticals Inc reports third quarter 2017 financial results and program updates

* Q3 revenue $9.6 million

* Q3 revenue view $16.1 million -- Thomson Reuters I/B/E/S

* Conatus Pharmaceuticals Inc - qtrly ‍net loss per share $0.13 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below